Authors: Kanda, Y Mineishi, S Saito, T Seo, S Saito, A Ohnishi, M Suenaga, K Niiya, H Nakai, K Takeuchi, T Kawahigashi, N Shoji, N Ogasawara, T Tanosaki, R Kobayashi, Y Tobinai, K Kami, M Mori, S Suzuki, R Kunitoh, H Takaue, Y

Citation: Y. Kanda et al., Pre-emptive therapy against cytomegalovirus (CMV) disease guided by CMV antigenemia assay after allogeneic hematopoietic stem cell transplantation: asingle-center experience in Japan, BONE MAR TR, 27(4), 2001, pp. 437-444

Authors: Ando, M Yokozawa, T Sawada, J Takaue, Y Togitani, K Kawahigashi, N Narabayashi, M Takeyama, K Tanosaki, R Mineishi, S Kobayashi, Y Watanabe, T Adachi, I Tobinai, K

Citation: M. Ando et al., Cardiac conduction abnormalities in patients with breast cancer undergoinghigh-dose chemotherapy and stem cell transplantation, BONE MAR TR, 25(2), 2000, pp. 185-189

Authors: Saito, M Nakamura, N Nagai, M Shirakawa, K Sato, H Kawahigashi, N Furukawa, Y Usuku, K Nakagawa, M Izumo, S Osame, M

Citation: M. Saito et al., Increased levels of soluble Fas ligand in CSF of rapidly progressive HTLV-1-associated myelopathy/tropical spastic paraparesis patients, J NEUROIMM, 98(2), 1999, pp. 221-226